(From Broad Clinical Labs)

RNA Research for All: How Advances in Total RNA Sequencing are Transforming Accessibility

The study of the transcriptome has revolutionized our understanding of gene expression and regulation across biological systems. RNA sequencing (RNA-Seq) has emerged as a fundamental approach to this analysis, providing unprecedented insights into cellular function in both health and disease contexts. Despite its importance, comprehensive transcriptome analysis has historically been limited by technical challenges, high costs, and complex workflows that placed it beyond the reach of many research laboratories.

Recent technological advancements in Total RNA Sequencing are making comprehensive transcriptome analysis more accessible, enabling researchers across diverse fields to leverage this powerful approach. Unlike traditional messenger RNA (mRNA) sequencing that primarily captures polyadenylated transcripts, Total RNA Sequencing offers a broader view of the transcriptome, including both coding and non-coding RNA species that play critical roles in cellular regulation. ​Broad Clinical Labs has been at the forefront of this transformation, pioneering innovative approaches that combine globin and ribosomal RNA (rRNA) depletion with unique molecular identifiers (UMIs) to dramatically enhance transcript detection capabilities while overcoming long-standing technical barriers. ​These advances represent more than incremental improvements – they signal a paradigm shift in how we approach transcriptome research, who can participate in this research, and what questions can be answered…